Swisse

Main information

  • Trade name:
  • Swisse Ultiboost Magnesium, Calcium + D3
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • Swisse Ultiboost Magnesium, Calcium + D3
    Australia
  • Language:
  • English

Other information

Status

  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 219663
  • Last update:
  • 08-10-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:

219663

Swisse Ultiboost Magnesium, Calcium + D3

ARTG entry for

Medicine Listed

Sponsor

Swisse Wellness Pty Ltd

Postal Address

111 Cambridge Street,Collingwood, VIC, 3066

Australia

ARTG Start Date

28/01/2014

Product category

Medicine

Status

Active

Approval area

Listed Medicines

Products

1. Swisse Ultiboost Magnesium, Calcium + D3

Product Type

Single Medicine Product

Effective date

18/08/2016

Warnings

Vitamins can only be of assistance if the dietary vitamin intake is inadequate. OR Vitamin supplements should not replace a balanced diet.

If symptoms persist consult your healthcare practitioner (or words to that effect).

Standard Indications

Source of calcium. A diet deficient in calcium can lead to osteoporosis in later life.

Source of calcium. May assist in the prevention and/or treatment of osteoporosis.

Vitamin D helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life

Aids, assists or helps in the maintenance of general well-being

Specific Indications

- Vitamin D and Calcium help in the development and maintenance of healthy bones and teeth/supports bone health/healthy bones and teeth.

- Contains vitamin D to help increase calcium absorption.

- Vitamin D promotes the body's absorption of calcium, important to maintain healthy bones and teeth.

- Source of/contains Calcium to help supplement a diet low in dietary calcium.

- Vitamin D supplementation may assist in regulation of calcium metabolism and bone mineralisation in those not obtaining sufficient vitamin D due to

diet or lifestyle factors/assists with the absorption and delivery of calcium to the bone.

- Calcium requirements may be increased with age, gender, diet, pregnancy, lactation, and during/following menopause.

- Women's calcium requirements are increased during/after menopause.

-The human skeleton consists of 206 bones that provide a framework for the body to help maintain shape, protect vital organs and provide a place for

muscles and supporting structures to attach.

- Bones also function as a site for mineral storage and blood formation.

- Magnesium helps the body to metabolise carbohydrates and fats.

- Magnesium is involved in the production of cellular energy/may assist with cellular energy production/helps support/support cellular energy production.

- Magnesium helps support healthy muscle function.

- Magnesium supports muscle relaxation by competitively binding to receptor sites normally reserved for calcium, which is the mineral that causes

muscles to contract. A depletion of Magnesium, due to low dietary intake, may lead to muscle cramps and spasms/Magnesium supplementation may

provide support for muscle cramps and spasms when dietary intake of magnesium is low

- Calcium and magnesium work together to cause the contraction and relaxation of muscles.

Magnesium supplementation may provide support for muscle cramps and spasms when dietary intake of magnesium is low/ Increased calcium and a

depletion of magnesium, due to low dietary intake, may lead to muscle cramps.

- Vitamin D helps support/maintain general health and wellbeing.

- Calcium helps support/maintain general health and wellbeing.

- Magnesium helps support/maintain general health and wellbeing.

-Magnesium helps support a healthy nervous system/nervous system support.

- Adequate levels of magnesium are important during times of stress.

- Magnesium plays an important role in supporting adrenal health, the adrenal glands have a key role in the body's response to stress.

- Factors such as diet and excess alcohol intake may reduce magnesium levels

- Adequate levels of magnesium contribute to a healthy cardiovascular system/help to support heart health/assists a health cardiovascular system.

- Magnesium plays a structural role in bones, it is also required for the transport of calcium across cell membranes.

- Contains a form of bioavailable magnesium (citrate) to help magnesium absorption

Additional Product information

Pack Size/Poison information

Pack Size

Poison Schedule

Components

1. Formulation 1

Dosage Form

Tablet, film coated

Route of Administration

Oral

Visual Identification

Active Ingredients

Calcium citrate

1.184 g

Public Summary

Page 1 of

Produced at 26.11.2017 at 03:31:40 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

colecalciferol

.0062 mg

Magnesium citrate

232.05 mg

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 2 of

Produced at 26.11.2017 at 03:31:40 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

There are no safety alerts related to this product.

22-10-2018

EU/3/10/815 (Pfizer Europe MA EEIG)

EU/3/10/815 (Pfizer Europe MA EEIG)

EU/3/10/815 (Active substance: Sildenafil citrate) - Transfer of orphan designation - Commission Decision (2018)6993 of Mon, 22 Oct 2018 European Medicines Agency (EMA) procedure number: EMA/OD/068/10/T/01

Europe -DG Health and Food Safety

15-5-2018

Effentora (Teva B.V.)

Effentora (Teva B.V.)

Effentora (Active substance: fentanyl citrate) - PSUSA - Modification - Commission Decision (2018)3013 of Tue, 15 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/1369/201704

Europe -DG Health and Food Safety